Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Chystáte se opustit lokální stránky Czech Proto budete přesměrování na celosvětové stránky, které jsou dostupné?
Nezobrazujte znovu tuto zprávu
Ano
Ne

Vyhledávali jste podle

Hledali jste

Relevantní informace

Důležité kontakty

Připravované akce

Příbuzné produkty

Farmaceutika, všeobecně a speciální - Finanční toky

Nejdůležitější body

Výzkum a studie
Organizace
Upřesněte, prosím, svou studii podle segmentu trhu, aby bylo možno získat odpovídající ratingy a monitorované údaje.
  DatumTyp dokumentu Název Emitent/entita
27 Mar 2024 Rating Action Moody's affirms Cencora's Baa2 senior unsecured rating, outlook revised to positive AmeriSource Hea...
Bergen Brunswig...
Bergen Brunswig...
Bergen Capital ...
Bergen Capital ...
Bergen Capital ...
Cencora, Inc.
Durr-Fillauer M...
PharMerica, Inc...
27 Mar 2024 Rating Action Moody's upgrades McKesson's senior unsecured rating to A3, outlook stable California Gold...
General Medical...
McKesson Canada...
McKesson Corpor...
McKesson Financ...
McKesson Financ...
Mckesson Financ...
Mckesson Financ...
Mckesson Financ...
14 Dec 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers ADVANZ PHARMA H...
AI Sirona (Luxe...
Almirall, S.A.
AstraZeneca Fin...
AstraZeneca PLC
Cerebro HoldCo ...
Cheplapharm Arz...
Cidron Aida Fin...
Covis Finco S.a...
Covis Parent SC...
...
27 Mar 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers ADVANZ PHARMA H...
AI Sirona (Luxe...
Almirall, S.A.
AstraZeneca Fin...
AstraZeneca PLC
Cerebro HoldCo ...
Cheplapharm Arz...
Cidron Aida Fin...
Covis Finco S.a...
Covis Parent SC...
...
15 Sep 2022 Rating Action Moody's upgrades Roche's rating to Aa2 and changes its outlook to stable Roche Finance E...
Roche Holding A...
Roche Holdings ...
Roche Kapitalma...
19 Apr 2022 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers ADVANZ PHARMA H...
AI Sirona (Luxe...
Almirall, S.A.
AstraZeneca Fin...
AstraZeneca PLC
Cerebro HoldCo ...
Cheplapharm Arz...
Cidron Aida Fin...
Covis Finco S.a...
Covis Parent SC...
...
19 Apr 2022 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical, Retailer, Packaged Goods and Other issuers in Asia Ampol Limited
Asahi Group Hol...
Astellas Pharma...
Baxalta Incorpo...
Beam Suntory In...
Bright Food Int...
China Mengniu D...
Coles Group Lim...
Coles Group Tre...
CSL Limited
...
31 Mar 2022 Rating Action Moody's withdraws credit ratings on multiple entities Absolut Bank (P...
Acron PJSC
Alfa-Bank
Alrosa Finance ...
ALROSA PJSC
AO RAIFFEISENBA...
Atomenergoprom,...
Aton Capital Gr...
Aton Financial ...
Atonline Limite...
...
10 Mar 2022 Rating Action Moody's downgrades the ratings of 95 Russian corporates Acron PJSC
Alrosa Finance ...
ALROSA PJSC
Atomenergoprom,...
Autobann (JSC S...
Avtoban-Finance...
Bashneft PJSOC
Borets Finance ...
Borets Internat...
Celtic Resource...
...
05 Nov 2021 Rating Action Moody's affirms Roche's Aa3 rating; positive outlook Roche Finance E...
Roche Holding A...
Roche Holdings ...
Roche Kapitalma...
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry